Marotta G, Bigazzi C, Bocchia M, Forconi F, Lauria F
Haematologica. 1998 Sep;83(9):853-4.
Long-lasting results achieved in 54 patients with aggressive non-Hodgkin lymphoma treated with Pro-MACE-CytaBOM regimen were evaluated. Twenty-four out of 54 (45%) patients achieved a complete remission and 13 of them are still in continuous remission with a median survival of 53.5 months. Interestingly, in 16 patients with intermediate grade histology we obtained an overall response rate of 100%.
对采用Pro-MACE-CytaBOM方案治疗的54例侵袭性非霍奇金淋巴瘤患者取得的长期疗效进行了评估。54例患者中有24例（45%）实现完全缓解，其中13例仍处于持续缓解状态，中位生存期为53.5个月。有趣的是，在16例中等组织学分级的患者中，我们获得的总缓解率为100%。
